Tag Archives: Innovation

Agreement will catalyse life sciences infrastructure

This week, ELIXIR has taken a step closer to becoming the central research infrastructure for life-science information in Europe. Denmark, Finland, the Netherlands, Sweden and the United Kingdom plus the European Molecular Biology Laboratory (EMBL) have signed a Memorandum of Understanding to kick start the construction of ELIXIR. Read more [...]

World class facilities plus coffee fosters enterprise in Ireland

With the arrival of fifteen cadavers, the anatomy teaching lab in Trinity College Dublin’s new Biomedical Sciences Institute will be complete. It is already fitted with fifteen stations, each with surgical lights, a high-definition video camera and flat-screen monitor. The instructor can show the feed from any station on the monitors – all controlled from an iPad. Read more [...]

Pharma grinding to a hault?

More evidence recently published by the 2011 Pharmaceutical R&D Factbook indicates that the pharma industry's productivity is continuing to decline. Fewer new molecular entities were launched in 2010 than in any other year in the past decade. The number of drugs entering Phase I, II and III clinical trials is also declining. R&D expenditure has also dropped to a three year low of $68 billion. Read more [...]

Framework 8 named “Horizon 2020”

Following an online naming competition, the next round of EC Framework funding is going to be called "Horizon 2020". Three names were shortlisted. Horizon 2020 received 3,055 votes against, 2,785 for Imagine 2020, and 2,478 for Discover 2020. In total, 8,318 votes were received. The full name being put forward this year as part of the legislative proposal for the new programme is "Horizon 2020 - the Framework Programme for Research and Innovation". Read more [...]